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Spontaneous Regression of Highly Immunogenic
Molluscum contagiosum Virus (MCV)-Induced Skin
Lesions Is Associated with Plasmacytoid Dendritic
Cells and IFN-DC Infiltration
William Vermi1, Simona Fisogni1, Laura Salogni2, Leo Scha¨rer3, Heinz Kutzner3, Silvano Sozzani2,
Silvia Lonardi1, Cristina Rossini1, Piergiacomo Calzavara-Pinton4, Philip E. LeBoit5 and Fabio Facchetti1
Molluscum contagiosum virus (MCV) infection induces self-limiting cutaneous lesions in an immunocompetent
host that can undergo spontaneous regression preceded by local inflammation. On histology, a large majority of
MCV-induced lesions are characterized by islands of hyperplastic epithelium containing infected keratinocytes
and surrounded by scarce inflammatory infiltrate. However, spontaneous regression has been associated with
the occurrence of a dense inflammatory reaction. By histology and immunohistochemistry, we identified MCV-
induced lesions showing a dense inflammatory infiltrate associated with cell death in keratinocytes
(inflammatory Molluscum contagiosum (I-MC)). In I-MC, hyperplastic keratinocytes were highly immunogenic
as demonstrated by the expression of major histocompatibility complex class I and II molecules. Immune
cell infiltration consisted of numerous cytotoxic T cells admixed with natural killer cells and plasmacytoid
dendritic cells (PDCs). Accordingly, a type I IFN signature associated with PDC infiltration was demonstrated in
both keratinocytes and inflammatory cells. Among the latter, a cell population resembling IFN-DC
(CD123þCD11cþCD16þCD14þMxAþ ) was identified in proximity to islands of apoptotic keratinocytes. In
vitro–generated IFN-DCs expressed a strong cytotoxic signature, as demonstrated by high levels of tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas ligand (FasL). This study establishes a
previously unreported model to underpin the role of innate immune cells in viral immune surveillance.
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INTRODUCTION
Molluscum contagiosum (MC) is a common benign viral
infection affecting the skin and mucosal membranes. The
Molluscum contagiosum virus (MCV), a DNA poxvirus, is
responsible for the disease. In immune-competent hosts,
MCV-induced lesions can undergo spontaneous regression.
In immunodeficient patients MCV is responsible for more
extensive infections (Cotton et al., 1987; Schwartz and
Myskowski, 1992). Many patients and dermatologists note
that manipulation of a lesion, which leads to the extrusion of
molluscum bodies into the dermis and their exposure to
immune cells, can lead to marked perilesional erythema,
followed by the regression of other, non-traumatized lesions
(Epstein, 1992; Brown et al., 2006). These data indicate that
the immune system has a critical role in the control of viral
spread.
A large majority of MCV-induced tumor-like lesions are
characterized by islands of hyperplastic epithelium contain-
ing infected keratinocytes and surrounded by scarce inflam-
matory infiltrates. The latter finding suggests that the virus
adopts escape mechanisms from local immune surveillance
(reviewed in Moss et al., 2000; Seet et al., 2003). Genes
encoded by poxviruses can target key host immune genes
such as major histocompatibility complex (MHC) class I
molecules, chemokines, IFNs, and ILs, which ultimately
reduce the immunogenicity of infected cells and hamper the
recruitment and function of immune cells to the primary site
of infection (Senkevich et al., 1996; Krathwohl et al., 1997;
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Damon et al., 1998; Luttichau et al., 2000). Notably, in a
subgroup of MCV-induced lesions a dense dermal infiltrate
composed by macrophages and numerous T cells comprising
a portion of CD30þ activated T cells is observed (Guitart
and Hurt, 1999). Remarkably, dense local inflammation has
been associated with spontaneous regression, as demon-
strated by follow-up biopsies obtained from occasional case
reports (Steffen and Markman, 1980; Epstein, 1992).
This set of evidences suggests that in an immune-
competent host the occurrence of a spontaneous rejection
is tightly associated with a local immune response. To our
knowledge this represents a unique model to trace cellular
events leading to immune-mediate antiviral response to
cutaneous poxviruses. During a screening of MCV-induced
skin lesions, we identified cases showing a strong inflamma-
tory reaction associated with histological evidence of
keratinocyte cell death. We surmise that this finding was
representative of an ongoing and traceable active regression
induced by infiltrating immune cells. By extending this
analysis, we found that the occurrence of histological
regression of MCV lesions was strikingly associated with
local inflammation and increased immunogenicity of kerati-
nocytes. Immune cell infiltration in regressing MC consists of
cytotoxic T cells and innate immune cells. Among the latter,
clusters of type I IFN-producing plasmacytoid dendritic
cells represented a common feature. Of note, among type I
IFN-targeted cells, numerous IFN-induced dendritic cells
(IFN-DCs) formed clusters around areas of hyperplastic
epithelium. IFN-DCs, when generated in vitro, are equipped
with a strong cytotoxic signature, as demonstrated by high
levels of tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL), Fas ligand (FasL), and granulolysin.
RESULTS
A subgroup of MCV-induced skin lesions is heavily infiltrated
by innate and adaptative immune cells
Scant infiltration of leukocytes is typically observed in
MCV-induced skin lesions (Heng et al., 1989). Based on
their histology and content of CD45RBþ leukocytes, 36
MCV-induced lesions were categorized in two main patterns.
The first pattern (10 cases) was represented by non-inflamed
lesions (NI-MC) infiltrated by very scant CD45þ leukocytes
(Figure 1a), whereas the second pattern (26 cases; from here
on referred to as inflammatory MC (I-MC)) showed consistent
amounts of CD45þ infiltrating cells (Figure 1b). Inflammatory
cells in I-MC were either diffuse in the dermis or surrounded
islands of hyperplastic epithelium; of note, intraepithelial
infiltration was normally limited to the dermoepidermal
boundary (Figure 1b). In NI-MC the inflammatory cell
population was represented by rare CD163þ macrophages
and scattered CD11cþ cells (not shown). In contrast, I-MC
biopsies contained numerous CD3þ T cells (Figure 1c)
admixed with rare CD20þ B cells and CD3Perforinþ
CD56þ natural killer cells (not shown). Among lymphoid
cells only T cells directly surrounded the infected epithelium.
The antiviral response to Poxviruses requires CD8 T cells
sustained by T-helper 1 (Th1) cytokines (Stanford and
McFadden, 2005). CD3þ T cells mainly consisted of CD8þ
cytotoxic T cells expressing granzyme B (GrB) and perforin,
as revealed by double staining with immunohistochemistry
(Figure 1d); notably, a fraction of them also coexpressed the
activation marker CD30 (Figure 1e). The remaining T-cell
population included CD4þ T cells. Based on immunostain-
ing for T-bet and Foxp3 (forkhead box P3), a Th1-type
polarization of the immune response was obvious in I-MC, as
revealed by predominant nuclear expression of T-bet in
lymphoid cells (Figure 1f).
Figure 1. Cytotoxic T-cell infiltration and apoptotic cell death characterize
inflammatory Molluscum contagiosum (I-MC). Sections from non-inflamed
Molluscum contagiosum (NI-MC; a) and I-MC (b–h) are immunostained for
CD45RB (a, b), CD3 (c), CD8 (d1 and d2), CD30 (e), perforin (d1), granzyme
B (GrB; d2 and e), T-bet (f1), Foxp3 (f2), hematoxylin/eosin (g), and cleaved
caspase 3 (h). In NI-MC, scattered CD45þ cells are observed (a), whereas
I-MC are densely infiltrated by CD45þ leukocytes (b); intraepithelial
inflammatory cells are very rare. I-MC contain numerous CD3þ T cells (c),
including CD8þperforinþ (d1), CD8þGrBþ (d2), and CD30þ GrBþ cells
(e, inset). The large majority of T cells express T-bet (f1), with only rare
Foxp3þ cells (f2). In I-MC, numerous apoptotic keratinocytes occur at the
boundary between epithelium and stroma (g, inset, h). Secondary antibodies
are revealed with diaminobenzidine (DAB; brown in a–f and h), new fucsin
(red, CD8 in d2), and Ferangi blue (blue, CD8 in d1 and CD30 in e). Original
magnification  40 (a–c; scale bar¼500 mm), 200 (e, g, and h; scale
bar¼ 100 mm), and  400 (d1, d2, f1, f2, and insets in e and g; scale
bar¼ 50 mm).
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Increased immunogenicity and apoptotic cell death of
infected keratinocytes in I-MC
On hematoxylin and eosin stain, we noticed that apoptotic
cell death represented a common feature of I-MC (24/26
cases; 92.3%) and this observation was supported by the
demonstration of active caspase 3 expression by sparse
keratinocytes (Figure 1g and h) at the periphery of infected
epithelial lobules. No reactivity for anti-active caspase 3 was
observed in all 10 NI-MC cases (Supplementary Figure S1
online). The restriction of the foci of cell death to I-MC along
with their distribution at the periphery of MCV epithelium
suggested an ongoing immune response against virus-
infected keratinocytes. MCV-encoded genes can interfere
with the level of immunogenicity of infected cells by
targeting MHC class I (Senkevich et al., 1996; Senkevich
and Moss, 1998). Tissue sections from 10 I-MC and 10 NI-MC
cases were stained for MHC class I (MHC-I) and II molecules
(MHC-II), transporter associated with antigen processing 1 (TAP1)
and 2 (TAP2), Tapasin, and NF-kB (Figure 2a–h). In NI-MC
cases (10/10 cases), the large majority of epithelial cells
lacked MHC-I, MHC-II and TAP1 and TAP2, whereas NF-kB
was mostly retained in the cytoplasm. Remarkably, I-MC
showed marked changes of MHC molecules, with upregula-
tion of MHC-I, MHC-II, TAP1, and TAP2 (10/10 cases) and
nuclear translocation of NF-kB (7/10 cases); all these
alterations were particularly evident in keratinocytes at the
periphery of infected epithelium.
In summary, a bimodal spectrum of presentation is
observed in MCV-induced skin lesions. From one end,
NI-MC completely lack histological evidence of immune-
mediated regression and loose expression of MHC-I and II
molecules. On the other end, I-MC lesions are highly
immunogenic lesions with histological feature of an ongoing
immune-mediated regression process.
Infiltration of type I IFN-producing PDCs is a common
feature of I-MC
Plasmacytoid dendritic cells/IFN-producing cells (PDCs)
represent a well-characterized cell population (Facchetti
et al., 2003; Colonna et al., 2004; Liu, 2005) capable of
producing large amounts of type I IFN with a potential role in
antiviral defense mechanisms. Although PDCs were com-
pletely absent in NI-MC (10/10 cases; not shown), they were
regularly found in all 26 cases of I-MC (8/26 score 1; 18/26
score 2). PDCs were identified as medium-sized round
cells positive for CD123, TCL1 (T cell leukemia-1; Vermi
et al., 2004; Santoro et al., 2005) CD303/BDCA2 (blood
dendritic cell antigen-2), CD2AP (CD2-associated protein),
and BCL11A (B-cell lymphoma/leukemia 11A). PDCs were
distributed either in the form of variable-sized clusters
within dermal inflammatory nodules or as rim surrounding
islands of infected epithelium (Figure 3a and b). Using
double immunohistochemistry we found that BDCA2þ PDCs
showed cytoplasmic expression of GrB (Figure 3c), as
previously reported (Vermi et al., 2004, 2009; Santoro
et al., 2005); however, when measured, the GrB content
was reduced or absent in 48.4% of PDCs (Figure 3d).
Activation of PDCs by viruses results in the production of
high levels of type I IFN via Toll-like receptor-dependent
signals. Expression of MxA has been used as a surrogate
marker of type I IFN production (Farkas et al., 2001; Santoro
et al., 2005; Vermi et al., 2003). Immunostaining for anti-
MxA showed clearcut differences between the two subgroups
of MC lesions. In I-MC, a diffuse and strong cytoplasmic
expression of the protein was detectable in keratinocytes and
inflammatory cells (20/20 cases; Figure 3e), whereas NI-MC
were either negative (7/10 cases) or showed focal and weaker
MxA reactivity (3/10 cases; Figure 3f). To further investigate
the molecular effects of type I IFN production, the tyrosine-
phosphorylated form of STAT1 (signal transducer and acti-
Figure 2. Differential expression of major histocompatibility complex
(MHC)-I, MHC-II, TAP1, and NF-jB in Molluscum contagiosum (MC).
Sections from non-inflamed MC (NI-MC; a, c, e, and g) and inflammatory
MC (I-MC; b, d, f, and h) are immunostained for major histocompatibility
complex-11 (MHC-II; a, b), MHC-I (c, d), TAP1 (e, f), and NF-kB (g, h). In
NI-MC, MHC-II (a), MHC-I (c), and TAP1 (e) are restricted to stromal cells
and, for MHC-I and TAP1, to areas of normal skin. I-MC shows strong
reactivity for all these molecules (b, d, and f with corresponding insets),
at the periphery of infected epithelium. In NI-MC, NF-kB is restricted to
the cytoplasm (g), whereas the same molecule localizes to the nucleus of
keratinocytes in I-MC (h). Secondary antibodies revealed with
diaminobenzidine (DAB). Original magnification 40 (a–f; scale
bar¼ 500 mm),  200 (g and h; scale bar¼ 100 mm), and  400 (insets in
b, d, and f; scale bar¼50 mm).
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vator of transcription 1) was tested by immunohistochemistry.
In response to type I IFN binding, the JAK–STAT pathway is
activated and the STAT1 subunit becomes phosphorylated.
Nuclear translocation of a trimeric complex including phos-
phorylated STAT1 binds IFN-regulated response elements and
modulates the transcription of IFN-stimulated genes (Borden
et al., 2007). We found a strong nuclear reactivity for anti-
STAT1pY701 in I-MC (10/10 cases; Figure 3g). In particular,
STAT1pY701þ cells were represented by numerous keratino-
cytes surrounding infected cells as well as by leukocytes
infiltrating the dermis (inset in Figure 3g); only very weak
and focal reactivity was observed in keratinocytes of NI-MC
(Figure 3h). Finally, to validate our hypothesis that type I
IFNs are locally produced in I-MC, RNA was extracted from
17 MCV-induced lesions. Compared with NI-MC, IFN-a, IFN-g,
MxA, and CXCL10 (chemokine (C-X-C motif) ligand 10) were
strongly upregulated in I-MC containing PDCs and IFN-DCs
(Figure 4).
Altogether, these data indicate that large numbers of
type I IFN-producing PDCs infiltrate I-MC, and IFN target
cells are represented by keratinocytes and surrounding
immune cells.
A previously unreported population of CD11cþCD123þ DCs
resembling the so-called ‘‘IFN-DC’’ infiltrate I-MC
In the large majority of I-MC cases (25/26; 96%), we noticed
a population of large CD123þ cells showing abundant
cytoplasm and an elongated, slightly irregular nucleus (Figure
5a and c). These cells were frequently found in close
proximity of infected epithelium, admixed with PDCs. They
were negative for other PDC markers (BDCA2 and CD2AP;
not shown), CD207, and CD1a (not shown), as well as for
CD3, CD20, and CD56, but strongly reacted with CD11c
(Figure 5b and d). Notably, a large majority of them were
also negative for the macrophage-specific marker CD163
Figure 3. Accumulation of plasmacytoid dendritic cells (PDCs) in
inflammatory Molluscum contagiosum (I-MC) is associated with type I IFN
protein expression signature. Sections from I-MC (a–e, g) and non-inflamed
(NI)-MC (f and h) are immunostained for CD123 (a), BDCA2 (b–d), granzyme
B (GrB; c and d), MxA (e and f), and STAT1pY701 (g and h). In I-MC, PDCs
occur in the deep dermis or surround islands of infected epithelium (a, b) and
may contain large GrBþ granules (c), or totally lack GrB reactivity (d, black
arrows). In I-MC, a diffuse and strong reactivity for MxA (e) and nuclear
STAT1pY701 (g) of keratinocytes and inflammatory cells is obvious (inset in g).
In NI-MC, reactivity for MxA and STAT1pY701 is weak and focal (f and h).
Secondary antibodies revealed with diaminobenzidine (DAB; brown in a–h)
and Ferangi blue (blue, BDCA2 in c and d). Original magnification  40
(a, e–h; scale bar¼500 mm), 100 (a; scale bar¼ 200mm),  200
(b; scale bar¼ 100mm),  400 (inset in g; scale bar¼50 mm), and  600
(c and d; scale bar¼20 mm).
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Figure 4. Expression of IFNs and IFN-inducible genes in Molluscum
contagiosum (MC). Gene expression was evaluated using mRNA extracted
from inflammatory MC (I-MC) and non-inflamed MC (NI-MC). mRNA
expression (2-DCT) was normalized to 18S rRNA. Results are expressed
as arbitrary units.
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(not shown). The puzzling phenotype and morphology of these
cells prompted us to further characterize them by using single
immunostains on serial sections and, when feasible, double
immunostains. Among the tested markers, we found that a
large majority of CD123þCD11cþ cells were also CD14dim
and strongly reacted for CD16, CD40, HLA-DR, MxA, and
STAT1pY701 (Figure 5e, g3, g4, and h). Remarkably, a
fraction of them also stained for CCR7 (chemokine (C-C
motif) receptor 7), CD83 (Figure 5g1 and g2), and CD208/
DC-LAMP (not shown). We excluded a myeloid origin of
these cells either by myeloperoxidase immunostain (that
reacted with only few of them) and the chloroacetate esterase
histochemistry, which was negative (data not shown).
Overall, the phenotype of these cells is reminiscent of the
so-called ‘‘IFN-DC,’’ a dendritic cell type obtained in vitro by
short exposure to GM-CSF and type I IFN (Santini et al.,
2000). In addition to the ability of IFN-DCs to cross-present
viral antigen, they can exert TRAIL- and GrB-dependent
effector function. We found that CD11cþCD123þ cells in
I-MC were remarkably located in areas of keratinocyte
cell death and a fraction of them expressed TRAIL, GrB
(Figure 5f), but not perforin (not shown).
In summary, these data indicate that a, to our knowledge
previously unreported, cell type with unprecedented morpho-
logical and phenotypical feature and resembling the so-called
‘‘IFN-DC’’ is part of the local immune reaction in I-MC.
In vitro conditioning of peripheral blood monocytes by type I
IFN generates CD11cþCD123þ IFN-DCs with a strong
cytotoxic signature
To further extend the comparison between the
CD123þCD11cþ population detected in vivo and ‘‘IFN-
DC,’’ circulating monocytes were cultured in vitro in
the presence of GM-CSF and type I IFN. At the end of
the 4-day culture protocol, a certain degree of heterogeneity
was present in the cell culture, with a first population
characterized by low expression of CD1a and CD14 and high
expression of MxA and CD16 (Figure 6a), and a second
population higher positive for CD1a but poorly expressing
MxA and CD16. In their whole, IFN-DCs were CD123þ and
CD11cþ (Figure 6b) and expressed higher levels of FasL and
TRAIL mRNA than classic monocyte-derived DCs (Figure 6b).
Therefore, these in vitro data further strengthen the correla-
tion between tissue CD123þCD11cþ cells and IFN-DCs.
Finally, using quantitative PCR (qPCR) of NI-MC versus I-MC
we found that Axl, TRAIL, and Lox1, the genes highly
expressed in IFN-DCs (Scutera et al., 2009; Parlato et al.,
2010), are strongly upregulated in I-MC (Figure 4).
DISCUSSION
In immune-competent patients, spontaneous regression of
MCV-induced lesions is commonly preceded by clinical signs
of inflammation (Epstein, 1992; Brown et al., 2006). The
cellular mechanisms underling this event are still incomple-
tely understood. This study documents the occurrence of a
composite inflammatory reaction to MCV-induced lesions
associated with histological regression. We found that
histological features of ongoing regression were tightly
correlated with the occurrence of a composite local immune
reaction (here referred as I-MC). Immune cells consist of
effector T cells admixed with PDC and a, to our knowledge
previously unreported, cell type resembling the so-called
‘‘IFN-DC.’’ Remarkably, immune cell infiltration was paral-
leled by increased immunogenicity of infected keratinocytes.
To our knowledge, this finding establishes a unique model
to underpin cellular mechanisms of the antiviral response to
poxviruses.
Members of the Poxviridae family are particularly adept at
escape from the host immune system by using different
Figure 5. IFN-induced dendritic cells (IFN-DCs) occur in inflammatory
Molluscum contagiosum (I-MC) lesions. All sections are from I-MC and
stained for CD123 (a), CD11c (b, d, f, and h2), hematoxylin/eosin (c), active
caspase-3 (d), CD14 (e1), CD16 (e2), TRAIL (f1), GrB (f2), CCR7 (g1), CD83
(g2), CD40 (g3), MHC-II (g4), MxA (h1), and STAT1pY701 (h2). Serial sections
(a, b) illustrate numerous large CD123þ cells (a) coexpressing CD11c (b)
with round-to-elongated nucleus and ample cytoplasm (c), localized in areas
of keratinocytes apoptosis (a–d and f). These cells express CD14 (e1), CD16
(e2), CCR7 (g1), CD40 (g3), MHC-II (g4), MxA (h1), and STAT1pY701 (h2).
A more limited fraction is also positive for TRAIL (f1) GrB (f2) and CD83 (g2).
Secondary antibodies revealed with diaminobenzidine (DAB; brown in a, b,
d–h2), new fucsin (red, CD11c in f2 and h2), and Ferangi blue (blue, CD11c
in d and f1). Original magnification 200 (a, b, and f; scale bar¼ 100mm),
400 (c–e, g, h; scale bar¼50 mm).
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strategies that sabotage components of the inflammatory
response (reviewed in Moss et al., 2000; Seet et al., 2003).
Genes encoded by poxviruses can target key host genes that
ultimately reduce the immunogenicity of infected cells and
hamper the recruitment of immune cells (Senkevich et al.,
1996; Krathwohl et al., 1997; Damon et al., 1998; Luttichau
et al., 2000). One of the remarkable findings of this study
is represented by the detection of high numbers of PDCs in
I-MC. Accumulation of PDCs in viral infections has been
reported only in few conditions, represented by acute
cutaneous varicella infection (Gerlini et al., 2006) and
hepatitis C virus positive hepatitis (Lau et al., 2008). PDCs
are capable of producing large amounts of type I IFNs and
possess features of DCs (Grouard et al., 1997; Cella et al.,
1999, 2000). They circulate through the blood (O’Doherty
et al., 1994; Sorg et al., 1999) and colonize lymphoid organs,
but are very scant in peripheral tissues, where they
accumulate only in pathological conditions such as cancer
and autoimmune diseases (Facchetti et al., 2003; Colonna
et al., 2004). Clues for a direct role of PDCs in the response
against viruses come from clinical and laboratory findings.
PDCs sense viral RNA and DNA, because of their repertoire
of Toll-like receptors (Kadowaki et al., 2001; Krug et al.,
2001, 2004a, b; Lund et al., 2003), and secrete high amounts
of type I IFN in response to viruses (Cella et al., 1999; Barchet
et al., 2005). The number of peripheral blood PDCs of
patients infected by HIV, hepatitis B virus, and hepatitis C
virus is severely diminished (Donaghy et al., 2001; Duan
et al., 2004; Kanto et al., 2004). In HIV, their reduced
frequency correlates with disease progression and occurrence
of opportunistic infections or Kaposi’s sarcoma (Soumelis
et al., 2001).
PDCs might directly participate in the killing of infected
cells via different effector mechanisms (Vermi et al., 2004;
Santoro et al., 2005; Chaperot et al., 2006; Hardy et al.,
2007; Stary et al., 2007), or represent the primary source of
proinflammatory chemokines and type I IFN (Penna et al.,
2002a, b). In this study, we found that only 50% of BDCA2þ
cells in I-MC express GrB, a key effector of the granule
pathway primarily involved in the clearance of pathogen-
infected cells. The significance of GrB expression and release
by PDCs is still a matter of debate. It is of note that PDCs
found in Imiquimod-treated skin cancer lack GrB (Stary et al.,
2007 no. 5462). Using qPCR of I-MC versus NI-MC and using
antibodies directed against MxA and STAT1pY701, we found
that IFN-a is locally produced and paralleled by a type I IFN
gene expression signature. Type I IFN-targeted cells were
represented by keratinocytes and inflammatory cells. Nota-
bly, infected keratinocytes composing I-MC lesions showed
strong induction of MHC-I, MHC-II, TAP1, and TAP2, thus
suggesting a contribution of this cytokine in increasing
the immunogenicity of infected cells. Modulation of these
molecules is also largely dependent on IFN-g. Primary source
for this cytokine can be represented by T cells and natural
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killer cells infiltrating I-MC. Type I IFNs can modulate a
plethora of immune cells with innate and adaptative
functions including T cells (Kadowaki et al., 2000; Biron,
2001; Blanco et al., 2001; Krug et al., 2004a; Jego et al.,
2005). Accordingly, in I-MC, we found that T cells were
biased toward a Th1-type polarization as documented by the
dominant expression of the transcription factor T-bet and
abundant production of IFN-g by qPCR. In addition, a large
proportion of T cells was represented by CD8þ cytotoxic
T cells expressing perforin and GrB; notably, a fraction of
them also coexpressed the activation marker CD30.
As additional proof that type I IFN represents a key
cytokine in I-MC, we documented the existence of a
cell population phenotypically resembling the so-called
‘‘IFN-DC,’’ a recently identified DC population that can be
generated in vitro by type I IFN conditioning of peripheral
blood monocytes (Santini et al., 2000, 2003, 2005, 2009;
Montoya et al., 2002; Ferrantini et al., 2008). In this study, we
showed the CD123þCD11cþ cells found in I-MC lack
lymphoid- and natural killer lineage markers and were
positive for HLA-DR, CD40, CD14, CD16, and CCR7. A
fraction of them also expressed CD83 and CD208, suggesting
ongoing activation. According to their type I IFN-biological
dependence, they also strongly reacted to anti-MxA and anti-
STAT1pY701. Finally, by qPCR of RNA obtained from I-MC,
we found high expression of Axl and Lox1, the two recently
identified IFN-DC-associated genes (Scutera et al., 2009;
Parlato et al., 2010). To our knowledge, the occurrence of a
similar population resembling IFN-DC has never been
documented in human tissues. We have been struck by the
very consistent finding that these cells were strategically
located in close proximity to active caspase-3þ apoptotic
keratinocytes, suggesting their direct involvement in
the rejection process via a caspase-dependent mechanism.
IFN-DCs can contribute in at least three different ways to the
local immune surveillance to viruses. IFN-DCs can cross-
present viral antigen to CD8 T cells, increase the immuno-
genicity of infected cells by producing IFNs, or exert effector
functions through GrB and TRAIL (Lapenta et al., 2006;
Santini et al., 2009). We were able to document GrB and
TRAIL expression by I-MC-associated CD11cþCD123þ
cells, and in vitro generated IFN-DCs showed a strong
induction of TRAIL and FasL. Our data of IFN-DC occurrence
in I-MC suggests a potential contribution of IFN-DCs in the
immune response to MCV.
The histopathology of I-MC partially mimics the inflam-
matory reaction observed in Imiquimod-treated skin cancers.
Imiquimod is a Toll-like receptor 7/8 agonist currently used
with efficacy in the topical treatment of various skin cancers.
Similarly to MC, clinical response is preceded by signs of
local inflammation, and Imiquimod-induced regression is
accompanied by a dense immune cell infiltration with
sizeable numbers of cytotoxic T cells, PDCs, and a consistent
population of CD11cþ myeloid DCs (Stary et al., 2007).
Similar to I-MC, PDCs produce high amounts of type I IFN
(Urosevic et al., 2005) and the CD11cþ myeloid DCs show a
cytotoxic profile (Stary et al., 2007). MC has been treated
with Imiquimod and complete clearance have been obtained
in 33% of the cases (Theos et al., 2004), suggesting that
appropriate boosting of local PDC is central to achieve
clinical benefit.
In summary, this study provides a detailed analysis of
cellular events associated with spontaneous regression of
MC and proposes a relevant role for the crosstalk among
two different DC subsets, namely PDCs and IFN-DCs.
We speculate that one of the driver events in this scenario
is represented by the recruitment of PDCs at the site of
infection. Proinflammatory chemokines (Penna et al., 2002a)
produced by PDCs might attract other innate and adaptative
immune cells. The availability of high amounts of type I IFN
can favor the switch of monocytes to IFN-DCs, the Th1
polarization of T cells, and the activation of natural killer
cells and CD8 T cells. This cellular environment would
provide sufficient amounts of type I and II IFNs to increase the
immunogenicity of infected keratinocytes by re-inducing
MHC molecules that would present viral antigens and
become more susceptible to recognition and elimination by
CD8 T cells. Finally, although not mechanistically proved in
this study, we favor the idea of an additional co-contribution
of PDCs and IFN-DCs as innate effectors (Stary et al., 2007).
In this view, such a better knowledge of the cellular events
leading to a productive immune surveillance against a virus-
induced ‘‘tumor-like’’ condition might suggest strategies to
properly boost the immune response against cancer.
MATERIALS AND METHODS
Patients and tissue samples
A total of 36 cases of MCV-induced skin lesions obtained from the
Departments of Pathology or the Dermatopathology laboratories of
three institutions (University of Brescia, Italy; University of California
at San Francisco School of Medicine, San Francisco, CA, USA; and
Friedrichshafen, Germany) were enrolled in the study. The diagnosis
was based on classical histological MC features (Cribier et al., 2001)
and molecular analysis (Supplementary Material online and Supple-
mentary Figure S1 online). Normal skin obtained from plastic surgery
was used as controls. All tissue samples were fixed in 10% buffered
formalin and embedded in paraffin. This study has been conducted
in adherence to the Declaration of Helsinki Principles and use of the
tissue material is regulated by the institutional board (Spedali Civili
di Brescia). Written, informed patient consent was obtained.
Histochemistry and immunohistochemistry
Details are reported in Supplementary Material online. Briefly, 4 mm
sections from formalin-fixed and paraffin-embedded tissues were
used for immunohistochemical staining, using a set of antibodies
whose specificities and main reactivity are reported in Supplemen-
tary Table S1 online.
Cell separation and culture
Human DCs. Peripheral blood mononuclear cells were isolated
from buffy coats of healthy blood donors (through the courtesy of the
Centro Trasfusionale, Spedali Civili di Brescia, Italy) by Ficoll
gradient (Amersham Biosciences, Uppsala, Sweden). IFN-DC was
performed as described (1) with only minor modifications in cell
density. Monocytes were isolated by immunomagnetic selection
(MACS Cell Isolation Kits; Miltenyi Biotec, Auburn, CA). Positively
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selected CD14þ monocytes were plated at the concentration of
1 106 cellsml–1 for indicated times in RPMI 1640 medium (GIBCO,
Invitrogen, Carlsbad, CA) with 10% heat-inactivated fetal bovine
serum (Lonza, Basel, Switzerland) supplemented with 50 ngml–1
GM-CSF and 20 ngml–1 IL-4 (both Peprotech, Rocky Hill, NJ) to
generate IL-4/DC, or with 100 ngml–1 GM-CSF and 1,000 IUml–1
IFN-a (Roferon, Roche, Milan, Italy) to generate IFN/DC.
Flow cytometry
Cells were washed and resuspended in phosphate-buffered saline
containing 1% human serum and incubated with anti-CD1a, CD14,
CD16, CD123, CD11c (BD PharMingen, San Jose, CA), and MxA
(see Supplementary Table S1 online). Cells were analyzed by flow
cytometry using a Partec flow cytometer (Munster, Germany).
Real-time PCR
For qPCR analysis, RNA was obtained from in vitro generated
IFN-DC and fixed tissue from NI-MC and I-MC cases. Details are
reported in Supplementary Material online.
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